Utah Medical Products, Inc.
UTMD
$64.51
-$0.48-0.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 37.53M | 38.52M | 38.63M | 38.83M | 39.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.53M | 38.52M | 38.63M | 38.83M | 39.27M |
| Cost of Revenue | 15.79M | 16.52M | 16.57M | 16.57M | 16.36M |
| Gross Profit | 21.75M | 22.00M | 22.06M | 22.26M | 22.92M |
| SG&A Expenses | 8.78M | 8.57M | 8.27M | 7.71M | 7.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.23M | 25.76M | 25.42M | 24.86M | 24.71M |
| Operating Income | 12.30M | 12.76M | 13.21M | 13.97M | 14.57M |
| Income Before Tax | 13.43M | 14.11M | 14.62M | 15.49M | 15.86M |
| Income Tax Expenses | 2.58M | 2.82M | 3.00M | 2.93M | 2.90M |
| Earnings from Continuing Operations | 10.85 | 11.29 | 11.62 | 12.55 | 12.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.85M | 11.29M | 11.62M | 12.55M | 12.96M |
| EBIT | 12.30M | 12.76M | 13.21M | 13.97M | 14.57M |
| EBITDA | 15.22M | 15.72M | 16.14M | 16.87M | 17.40M |
| EPS Basic | 3.38 | 3.48 | 3.53 | 3.74 | 3.78 |
| Normalized Basic EPS | 2.91 | 2.98 | 3.03 | 3.13 | 3.20 |
| EPS Diluted | 3.38 | 3.48 | 3.53 | 3.74 | 3.78 |
| Normalized Diluted EPS | 2.91 | 2.98 | 3.03 | 3.13 | 3.20 |
| Average Basic Shares Outstanding | 12.84M | 12.96M | 13.15M | 13.42M | 13.71M |
| Average Diluted Shares Outstanding | 12.84M | 12.96M | 13.15M | 13.42M | 13.71M |
| Dividend Per Share | 1.23 | 1.23 | 1.22 | 1.22 | 1.21 |
| Payout Ratio | 36.46% | 35.29% | 34.80% | 32.72% | 32.32% |